Investors - Press Releases
<< Back |
Tabula Rasa HealthCare Completes the Sale of SinfoníaRx and DoseMeRx
"The successful sale of these two businesses, along with the sale of PrescribeWellness in
TRHC completed the sale of DoseMeRx, an advanced precision dosing tool, on
Conference Call
As previously announced, TRHC will hold a conference call and webcast to discuss its fourth quarter and full year 2022 financial results on
About
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by words such as "believe," "will," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," "predict," "could," "potentially" or the negative of these terms or similar expressions. You should read these statements carefully because they discuss future expectations, contain projections of future results of operations or financial condition, or state other "forward-looking" information. These statements relate to, without limitation, our future plans, objectives, expectations, intentions, the completed sales of the SinfoníaRx and
View original content to download multimedia:https://www.prnewswire.com/news-releases/tabula-rasa-healthcare-completes-the-sale-of-sinfoniarx-and-dosemerx-301761687.html
SOURCE
TRHC Media Contact: Anthony Mirenda, amirenda@trhc.com, 908-380-2143; TRHC Investors: Frank Sparacino, fsparacino@trhc.com, 866.648.2767